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Glycogen synthase kinase-3b (GSK-3b/zeste-white-3/shaggy) is a negative regulator of the wnt signaling pathway which
plays a central role in the development of invertebrates and vertebrates; loss of function and dominant negative mutations
in GSK-3b lead to activation of the wnt pathway in Drosophila and Xenopus. We now provide evidence that lithium
activates downstream components of the wnt signaling pathway in vivo, leading to accumulation of b-catenin protein.
Our data indicate that this activation of the wnt pathway is a consequence of inhibition of GSK-3b by lithium. Using a
novel assay for GSK-3b in oocytes, we show that lithium inhibits GSK-3b from species as diverse as Dictyostelium
discoideum and Xenopus laevis, providing a biochemical mechanism for the action of lithium on the development of these
organisms. Lithium treatment also leads to activation of an AP-1±luciferase reporter in Xenopus embryos, consistent with
previous observations that GSK-3b inhibits c-jun activity. Activation of the wnt pathway with a dominant negative form
of GSK-3b is inhibited by myo-inositol, similar to the previously described effect of coinjecting myo-inositol with lithium.
The mechanism by which myo-inositol inhibits both dominant negative GSK-3b and lithium remains uncertain.
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INTRODUCTION 1989; Price and Heninger, 1994). The hypothesis is based
on the observation that lithium inhibits inositol monophos-
phatase (IMPase) in vitro (Berridge et al., 1989; Hallcher andLithium perturbs the development of diverse organisms
Sherman, 1980). Inhibition of IMPase is believed to lead toincluding Xenopus, zebra®sh, Dictyostelium, and sea ur-
depletion of endogenous inositol, preventing the formationchins. In Xenopus embryos, lithium treatment causes an
of inositol tris-phosphate (IP3). In support of this hypothesis,expansion of dorsal mesoderm, leading to formation of a
coinjection of myo-inositol with lithium prevents the te-second dorsal axis (Kao et al., 1986). In Dictyostelium, lith-
ratogenic actions of lithium in Xenopus embryos (Busa andium alters cell fate determination, blocking spore cell for-
Gimlich, 1989). However, when IMPase is inhibited com-mation and promoting stalk development (Maeda, 1970).
pletely in Xenopus embryos using the IMPase inhibitorTreatment of sea urchin animal blastomeres with lithium
L690,330 (Atack et al., 1993), which is 1000 times morecauses them to display a morphology resembling that of
potent than lithium, the embryos develop normally (Kleinisolated vegetal blastomeres (Horstadius, 1973).
and Melton, 1996). Thus, inhibition of IMPase is not suf®-The inositol depletion hypothesis is a widely accepted
cient for dorsalization of Xenopus embryos. Furthermore,explanation of the developmental effects of lithium, as well
mutants in Dictyostelium discoideum lacking phospholi-as the neuropsychiatric effects of lithium (Berridge et al.,
pase C (and unable to generate IP3 in response to extracellu-
lar signals) also develop normally, indicating that an intra-
cellular rise in IP3 is not necessary for spore cell develop-1 To whom correspondence should be addressed. Fax: 215-573-
4320. E-mail: pklein@genetics.upenn.edu. ment (Drayer et al., 1994). Taken together, these data
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indicate that the developmental effects of lithium are medi- MATERIALS AND METHODS
ated by another target or pathway.
Because of the close similarities between lithium treat-
Materials. Puri®ed, bacterially expressed GSK-3 was purchased
ment and ectopic activation of the wnt signaling pathway from New England Biolabs. b-Catenin protein, plasmid, and anti-
in Xenopus, we have investigated whether lithium acts on bodies were generous gifts from Ursula Gluck and Barry Gumbiner
a component of the wingless/int (wnt) signaling pathway (Memorial Sloan Kettering). Xenopus GSK-3b plasmids (XG73 and
(Klein and Melton, 1996). The wnt pathway is a highly con- XG114) were kindly provided by David Kimelman (University of
Washington). The collagenase promoter (AP-1)±luciferase con-served signaling pathway that regulates cell fate decisions in
struct was obtained from Nancy Colburn (NCI; Angel and Karin,vertebrates and invertebrates (reviewed in Perrimon, 1994,
1991; Dong et al., 1996). [g-32P]ATP was from Amersham. Western1996; Miller and Moon, 1996). Much of the pathway has
analysis was performed using enhanced chemiluminescence (ECL,been determined from detailed genetic analysis in Drosoph-
Amersham).ila. At present, identi®ed components of this signaling path-
Oocytes, embryos, and microinjection. Stage 6 Xenopus oo-way include wnts (the secreted ligands), frizzled (the wnt
cytes were obtained by collagenase treatment of excised ovaries
receptor), and the intracellular mediators disheveled, zeste- (Smith et al., 1994) and were microinjected with 10 nl for RNA
white 3/shaggy (or GSK-3b), and armadillo (or b-catenin; see and 10 ±20 nl for tau protein. Oocytes were cultured at 187C in
above reviews). In 10T1/2 cells, wingless signaling inhibits OR2/ (82.5 mM NaCl, 2.5 mM KCl, 1.0 mM CaCl2, 1.0 mM MgCl2,
GSK-3b enzymatic activity (Cook et al., 1996), consistent 1.0 mM Na2HPO4 , 5.0 mM Hepes, pH 7.8). For embryo experi-
ments, eggs were fertilized as described and cultured in 0.11MMRwith epistasis experiments in Drosophila, suggesting an in-
at 16 ±237C (11MMR is 0.1 M NaCl, 2.0 mM KCl, 1.0 mM MgCl2 ,hibitory role for GSK-3b/zw3-sgg in the wnt pathway. Wnt
2.0 mM CaCl2, 0.1 mM EDTA, 5.0 mM Hepes, pH 7.4). Embryossignaling leads to stabilization of b-catenin protein in Dro-
were transferred to 3% Ficoll in 0.51MMR for microinjection andsophila (Peifer et al., 1994; van Leeuwen et al., 1994) as
then returned to 0.11MMR. For DN-GSK-3 RNA and myo-inositolwell as Xenopus (Yost et al., 1996). This is associated with
injections, embryos were injected in the subequatorial region of aa translocation of b-catenin to the nucleus in cells re-
ventral±vegetal blastomere at the 16-cell stage with either 5 or 10
sponding to wnt signals (Funayama et al., 1995; Schneider nl. In most experiments, 10 embryos were harvested at stage 8 to
et al., 1996; Yost et al., 1996). In addition, ectopic expression assess the level of DN-GSK-3 protein translated from the injected
of conserved genes, including wnts, disheveled, and b-ca- RNA, and the rest of the embryos were scored at stages 30±35.
tenin, leads to second axis formation in Xenopus, similar to GSK-3 assays. In vitro phosphorylation of tau was performed
as described previously (Klein and Melton, 1996), except that thelithium treatment. Our attention was focused on glycogen
reactions were incubated at 257C and bacterially expressed tau (50synthase kinase-3b (zeste-white 3/shaggy) based on the ob-
mg/ml) was used. Samples were taken at 0, 5, 10, 15, 20, 25, andservations that disruption of the Dictyostelium GSK-3b
30 min, adjusted to 11 Laemmli sample buffer, and analyzed bygene (Harwood et al., 1995) is phenocopied by lithium treat-
polyacrylamide gel electrophoresis (7.5% SDS gels). After electro-ment (Maeda, 1970) and that expression of a dominant nega-
phoresis, gels were either ®xed and dried for autoradiography ortive mutant of GSK-3b causes duplication of the dorsal axis
transferred to nitrocellulose for Western blotting. To measure in
in Xenopus, also similar to lithium treatment (Dominguez vivo phosphorylation of tau by GSK-3b, RNA (10 ng) encoding
et al., 1995; He et al., 1995; Pierce and Kimelman, 1995). Xenopus or Dictyostelium GSK-3b was injected into stage 6 oo-
Therefore, we have previously proposed that the diverse cytes. After 16 hr (at 187C), 10±20 ng tau protein was injected and
developmental effects of lithium are mediated through di- oocytes were incubated (237C) for the times indicated in the ®gures.
For lithium treatment, oocytes were transferred to OR2/ con-rect inhibition of GSK-3b (Klein and Melton, 1996). In sup-
taining 20 mM LiCl for 10 min prior to tau injection and wereport of this hypothesis we have shown that lithium, but
returned to the OR2//LiCl after injection. For each sample, 10not other monovalent cations, inhibits puri®ed GSK-3b in
oocytes were homogenized in 100 ml tau lysis buffer (100 mM Tris,vitro with a Ki  2.1 mM and does not inhibit several other
pH 6.5, 0.5 mM MgCl2, 1 mM EDTA, 1 M NaCl, 2 mM DTT, 50protein kinases (Klein and Melton, 1996). Another labora-
mM NaF, 0.1 mM NaVO4) and centrifuged at 20,000g for 5 min attory has recently con®rmed that lithium inhibits GSK-3b
47C. Supernatants were adjusted to 11 sample buffer, electropho-
with a Ki  1-2 mM (Stambolic et al., 1996). resed on 7.5% SDS±PAGE, and analyzed by Western blot using
In this paper, we demonstrate that lithium inhibits GSK- primary antibodies that recognize speci®c phosphorylated epitopes
3b activity in vivo and mimics the biochemical effect of wnt on tau (PHF-1) or all forms of tau [T14/T46 (Kosik et al., 1988)].
signaling by leading to stabilization of b-catenin protein in b-Catenin stabilization in oocytes. b-Catenin protein (7 ng per
oocyte) or RNA (5 ng/oocyte) was injected into oocytes which wereXenopus oocytes and embryos. Using a novel assay in oo-
then incubated at 187C with or without 20 mM LiCl for the timescytes, we ®nd that GSK-3b from widely diverse species
indicated in Fig. 3 (protein injections) or overnight (RNA injec-(whose development is sensitive to lithium) is equally in-
tions). Oocytes were then lysed (10 oocytes per 100 ml) in oocytehibited by lithium. We also provide evidence that suggests
lysis buffer [20 mM Tris±Cl, pH 7.5, 150 mM NaCl, 1 mM EDTA,that c-jun, which has been shown previously to be inhibited
1 mM PMSF, leupeptin (10 mg/ml), aprotinin (10 mg/ml)] and centri-by GSK-3, may be activated in vivo by lithium treatment.
fuged as above, and supernatants were analyzed by SDS±PAGE and
Finally, myo-inositol is shown to reverse the dorsalizing Western blotting with anti-b-catenin antibody. DN-GSK-3 RNA
effect of the dominant inhibitory form of GSK-3b, raising was also injected (where indicated) at 5 ng/oocyte.
the possibility that myo-inositol rescue of lithium teratoge- c-jun activity in embryos. One-cell embryos were injected with
nicity is through a more indirect mechanism than replen- plasmid containing the collagenase (AP-1)± luciferase reporter (100
pg supercoiled DNA) and incubated in 0.11 MMR with 0±20 mMishing depleted inositol pools.
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LiCl. A second group of embryos was injected with an SV40±lucif-
erase reporter (also 100 pg) and incubated with or without 20 mM
LiCl. At stage 12 [when endogenous c-jun is ®rst expressed (Dong
et al., 1996)], 10 embryos were harvested for luciferase assays using
the Promega luciferase assay system (Promega) according to the
manufacturer's protocol and light output was measured with a scin-
tillation counter.
RESULTS
GSK-3b Activity in Xenopus Oocytes
To study GSK-3b activity within the cellular milieu, we
have developed an assay system using GSK-3b expression
in Xenopus oocytes. Tau protein, a microtubule-associated
protein expressed in mammalian brain, was chosen as a
substrate for GSK-3b. Tau is the principal component of the
paired helical ®laments and neuro®brillary tangles found in FIG. 1. In vitro and in vivo phosphorylation of tau protein by
Alzheimer's disease and has been shown previously to be a GSK-3b. (A) Recombinant, puri®ed GSK-3b was incubated with [g-
substrate for GSK-3b as well as a number of other kinases, 32P]ATP in the presence of tau protein. [g-32P]ATP incorporation
including mitogen-activated protein (MAP) kinase, protein can be seen at 5 min (lane 2) and continues to increase over 30
min. Phosphorylated tau protein was also detected by immuno-kinase A, and cyclin-dependent kinase-5 (Lee, 1995; Mande-
staining with PHF1, an antibody speci®c for tau phosphorylated atlkow and Mandelkow, 1993). A large panel of antibodies
serine residues 396 and 404. GSK-3 phosphorylated tau can also bethat recognize only speci®c, phosphorylated epitopes in tau
seen in this assay at 5 min (lane 2) and continues to accumulatehas been generated. This includes sites phosphorylated by
over 30 min. (B) Stage 6 Xenopus oocytes expressing GSK-3b wereGSK-3b (PHF-1) (Lovestone et al., 1994; Otvos et al., 1994).
injected with tau protein and samples were harvested at 5 min, 30
Thus, tau offers the advantages that it is not normally ex- min, 1.5 hr, 3 hr, and 6 hr for Western blot analysis with PHF-1
pressed in oocytes and phosphorylation of speci®c sites can antibody. In control oocytes (0GSK-3b RNA) (lanes 1±5) tau is
be readily followed by Western blotting. not phosphorylated at Ser-396 or 404 during the 6-hr incubation.
We ®rst determined that tau phosphorylation occurs However, in oocytes injected with GSK-3b RNA (lanes 6±10) PHF1
within a reasonable time frame in vitro and in Xenopus staining can be identi®ed at 5 min and increases in intensity over
time. Equal loading of tau protein is shown in lower panels withoocytes expressing GSK-3b. Tau phosphorylation by GSK-3
an antibody that recognizes all forms of tau protein.has been demonstrated by several labs, but in many studies,
analyses required GSK-3b and tau to be coincubated for 30
min to 24 hr (Hanger et al., 1992; Mandelkow et al., 1992;
Mulot et al., 1994) and coexpression studies in cell lines
involved even longer time periods. We have found that GSK- mRNA encoding Xenopus GSK-3b (Pierce and Kimelman,
1995). After 16 hr, tau protein was injected and oocytes3b will phosphorylate tau within 5 min, both in vitro and
in vivo. As shown in Fig. 1, in vitro phosphorylation of tau were then harvested at multiple time points for analysis by
immunoblotting. As shown in Fig. 1B, tau is rapidly (withinis evident by incorporation of 32P within 5 min and this is
re¯ected by the appearance of immunoreactivity to the 5 min) phosphorylated at serines 396 and 404, as determined
by immunoreactivity with the PHF-1 antibody, and thisPHF-1 antibody, a monoclonal antibody that speci®cally
recognizes tau protein when phosphorylated at serines 396 phosphorylation persists for up to 6 hr. The level of tau
protein did not change signi®cantly over this time period,and 404 (Otvos et al., 1994).
To measure GSK-3 activity within oocytes, bacterially although there was a decrease in electrophoretic mobility
in parallel with the increased phosphorylation of tau, asexpressed tau protein (Goedert and Jakes, 1990) was injected
into stage 6 Xenopus oocytes, which were then incubated determined by immunoblotting with antibodies indifferent
to phosphorylation state (Fig. 1B, T14/T46). Thus, the activ-for 5 min to 6 hr, lysed, and subjected to immunoblotting
with PHF-1 antibody or with antibodies that recognize both ity of expressed GSK-3b can be readily measured in the
oocyte without interference from the high-backgroundphosphorylated and unphosphorylated tau. No signal was
seen when using the PHF-1 antibody (Fig. 1B), suggesting phosphorylation by other protein kinases seen in mamma-
lian cell lines (Sperber et al., 1995). Western blotting thethat serines 396 and 404 are not highly phosphorylated un-
der these conditions and consistent with a relatively low same extracts with an anti-GSK-3 antibody showed that
GSK-3 was present at equal levels throughout the assaylevel of endogenous GSK-3 activity. After prolonged incuba-
tion, some lower electrophoretic mobility forms of tau were in oocytes injected with RNA but was not detectable in
uninjected oocytes (data not shown).detected (Fig. 1B, T14/46) which may re¯ect phosphoryla-
tion by other protein kinases present in the oocyte. To test whether lithium inhibits Xenopus GSK-3b in
vivo, we applied this oocyte assay system in the presenceGSK-3b was then expressed in oocytes by injection of
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of lithium chloride. Thus, oocytes were injected with GSK-
3b mRNA as described above, incubated for 16 hr, and then
transferred to either control medium or medium containing
20 mM LiCl. Tau protein was injected, oocytes were incu-
bated for 2 hr, and then oocytes were harvested for Western
blot analysis as above. As shown in Fig. 2A, PHF-1 immuno-
reactivity is seen only in oocytes expressing GSK-3b (com-
pare lanes 2 and 3). In the presence of LiCl, the GSK-3b
activity is markedly inhibited (lane 4), while the level of
GSK-3b protein is not reduced by lithium treatment (Fig.
2B). The extracellular concentration of LiCl was varied from
0 to 50 mM and GSK-3b activity was measured, as shown
in Fig. 2C; clear inhibition was observed at 5 to 10 mM LiCl
and PHF-1 immunoreactivity was nearly undetectable at 20
to 50 mM. It should be noted that, after a 4-hr incubation
of embryos in LiCl, the intracellular Li/ concentration does
not exceed 5% of the extracellular concentration (Brecken-
ridge et al., 1987). We expect that the intracellular concen-
trations of LiCl in our experiments are also considerably
lower than the extracellular concentration.
Therefore, lithium inhibits Xenopus GSK-3b in vivo, pro-
viding a highly plausible explanation for the dorsalizing ef-
fect of lithium on amphibian development. Lithium treat-
ment also phenocopies the gskA mutation (loss of GSK-3)
in D. discoideum, leading to a failure to produce spores and
an expansion of basal stalk cells. To test whether GSK-
3b from this primitive eukaryote is directly inhibited by
lithium, we subcloned GSKA into a Xenopus expression
vector and expressed the protein in oocytes. As shown in
Fig. 2A, Dictyostelium GSK-3b phosphorylates tau protein
(lane 5) as well as GSK-3b from Xenopus (lane 3) and this
activity is also inhibited by lithium (lane 6).
Activation of the wnt Signaling Pathway
in Xenopus by Lithium
Genetic epistasis experiments in Drosophila have sug-
FIG. 2. In vivo inhibition of GSK-3b by lithium. (A) Xenopusgested that zeste-white-3/shaggy, the Drosophila homolog
oocytes expressing GSK-3b were transferred to OR2/ containingof GSK-3b, is inhibited by wingless signaling, and this has
0 mM LiCl (lanes 3 and 5) or 20 mM LiCl (lanes 4 and 6) and werebeen con®rmed biochemically (Cook et al., 1996). One con-
injected with the tau protein. After 2 hr oocytes were harvestedsequence of this inhibition is an accumulation, due to pro-
for Western blot. Lane 1, no tau protein; lanes 2±6, tau injected.
tein stabilization, of b-catenin protein (armadillo in Dro- GSK-3b RNA injection and lithium treatment are indicated in the
sophila) in the responding cells (reviewed in Miller and ®gure. PHF1 and T14/T46 are as described in the legend to Fig. 1.
Moon, 1996). b-Catenin is essential for dorsal axis forma- Lanes 1, 3, and 4, injection of Xenopus GSK-3b RNA; lanes 5 and
tion in Xenopus embryos (Heasman et al., 1994) and also 6, injection of Dictyostelium GSK-3b RNA. (B) Selected samples
appears to be stabilized by inhibition of XGSK-3b activity from (A) were analyzed by Western blot using an anti-GSK-3 anti-
body, which recognizes Xenopus but not Dictyostelium GSK-3b.(Yost et al., 1996). Thus, activation of the wnt signaling
(C) Dose response for lithium inhibition. Oocytes were treated aspathway involves stabilization of b-catenin in vertebrates
in (A), but the concentration of LiCl was varied from 0 to 50 mM,and invertebrates, presumably acting through inhibition of
as indicated in the ®gure. After injection of tau protein, oocyteGSK-3b.
extracts were analyzed by Western blot using PHF-1 or T14/46To follow activation of the wnt pathway in oocytes and
antibodies as indicated.
embryos, we assayed b-catenin stabilization, as described
by others for Drosophila (van Leeuwen et al., 1994) and
Xenopus (Yost et al., 1996). RNA encoding b-catenin was
injected into oocytes with or without coexpression of DN- stabilization of b-catenin in embryos (Yost et al., 1996).
DN-GSK-3 also leads to accumulation of b-catenin in oo-GSK-3, a dominant negative form of GSK-3b. DN-GSK-3
has previously been shown to mimic the wnt pathway in cytes (Fig. 3A, lane 3). Wild-type GSK-3 had no apparent
effect on b-catenin accumulation in oocytes (Fig. 3A, laneXenopus embryos and has recently been shown to lead to
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LiCl in the buffer. At various times after injection and trans-
fer to LiCl, oocytes were homogenized and processed for
Western blot using anti-b-catenin antibody (also a generous
gift of Ursula Gluck and Barry Gumbiner). The level of in-
jected b-catenin protein falls in untreated oocytes with an
approximate half-life of 1 hr and is almost undetectable by
4 to 6 hr (Fig. 3B, lanes 40 and 60), while in the presence of
lithium, the injected protein persists at considerably higher
levels up to 6 hr after injection (Fig. 3B, lanes 4/ and 6/).
This stabilization of b-catenin protein by lithium continues
for at least 18 hr after injection (data not shown). Endoge-
nous b-catenin is present at much lower levels in oocytes
and is not readily detected under the conditions shown in
Figs. 3A and 3B (see Fig. 3B, lane 1). The recombinant b-
catenin contains several copies of the myc epitope at the
carboxy terminus causing the protein to migrate more
slowly in polyacrylamide gels than endogenous b-catenin.
Thus, the injected protein can be readily distinguished from
endogenous protein, ruling out the possibility that the pro-
tein levels seen in the presence of LiCl represent increased
protein synthesis.
Lithium also causes stabilization of b-catenin protein in
embryos, as shown in Fig. 3C. b-Catenin protein was in-
jected into the marginal zone of late two-cell embryos. At
the four-cell stage, embryos were treated with 0.3 M LiClFIG. 3. b-Catenin stabilization by lithium. (A) Xenopus oocytes
for 6 min (Kao et al., 1986) and then transferred to bufferwere injected with b-catenin RNA (lanes 1±4) and DN-GSK-3 RNA
containing 20 mM LiCl. Treated and untreated embryos(lane 3), wild-type GSK-3 RNA (lane 4), or incubated in 20 mM
LiCl (lane 2). Oocytes were incubated overnight in OR2/ and then were harvested at several time points after injection and
harvested for Western analysis. (B) b-Catenin protein was injected analyzed by Western blot as above. Again, lithium causes
into Stage 6 Xenopus oocytes and samples were taken for Western stabilization of injected b-catenin protein in embryos (Fig.
blotting at 0, 1, 2, 4, or 6 hr after incubation in OR2/ with 0 (0) 3C, compare lanes 40 and 4/), similar to DN-GSK-3 (Yost
or 20 mM (/) LiCl. un represents uninjected oocytes. (C) Two-cell et al., 1996) and consistent with activation of the wnt path-
embryos were injected with b-catenin protein and treated with way. A higher level of endogenous b-catenin is seen in em-
lithium or control buffer as described in the text. Embryos were
bryos (Fig. 3C) compared to oocytes (Figs. 3A and 3B), andharvested immediately after lithium treatment or at 4 hr (blastula
this does not appear to change signi®cantly in response tostage). 0 and / indicate control or lithium treated and un indicates
lithium, most likely because the majority of the endogenousuninjected embryos. inj, injected b-catenin; end, endogenous b-
protein is associated with cadherin and not accessible tocatenin protein. For all panels, b-catenin protein was visualized by
Western blot using anti-b-catenin antibody. regulation by the wnt pathway (Fagatto and Gumbiner,
1994; Yost et al., 1996; Schneider et al., 1996).
Activation of AP-1 by Lithium4), consistent with previous observations in embryos and
suggesting that GSK-3 is not limiting in this pathway (Yost The formal possibility remains that lithium leads to b-
catenin accumulation through a mechanism that is inde-et al., 1996).
These data indicate that GSK-3 activity is present endoge- pendent of GSK-3 inhibition. We therefore employed an
alternative assay of endogenous GSK-3 activity in embryos.nously in oocytes and can be monitored by following b-
catenin turnover. To address whether lithium inhibits en- The transcription factor c-jun has been shown by others to
be a substrate for GSK-3, both in vitro and in cell linesdogenous GSK-3, oocytes injected with b-catenin mRNA
were cultured in medium containing 20 mM LiCl. As shown overexpressing GSK-3 and c-jun. GSK-3 phosphorylates c-
jun at Thr-239, Ser-243, and Ser-249 near the DNA bindingin Fig. 3A (lane 2), lithium leads to accumulation of b-
catenin to an extent comparable to that of DN-GSK-3, sug- domain, inhibiting DNA binding and thus inhibiting c-jun
activity (Boyle et al., 1991; Plyte et al., 1992). We reasonedgesting that lithium alone can activate the wnt signaling
pathway through inhibition of endogenous GSK-3. To dem- that if lithium inhibits GSK-3 in embryos, it should lead to
an activation of endogenous c-jun. Embryos were injectedonstrate that this effect is mediated through stabilization
ofb-catenin protein rather than increased protein synthesis, at the one-cell stage with a reporter construct containing
the collagenase promoter, which includes an AP-1 site, up-puri®ed, recombinant b-catenin protein (gift of Ursula
Gluck and Barry Gumbiner) was injected into stage 6 oo- stream of the luciferase coding region (gift of Nancy Col-
burn; see Angel and Karin, 1991). Control embryos werecytes, which were then cultured with or without 20 mM
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FIG. 4. Lithium activates AP-1 transcriptional activity in Xenopus embryos. (A) One-cell embryos were injected with an AP-1± luciferase
reporter plasmid and cultured in the presence of 0±20 mM LiCl until stage 12 when embryos were harvested for luciferase assays. (B)
Luciferase activity with AP-1±luciferase and SV40±luciferase constructs in the presence (20 mM) or absence of LiCl. The values are
normalized to maximum activity for each reporter. The experiment was repeated ®ve times and in each case AP-1 activity was stimulated
in the presence of lithium (up to 145-fold), although the magnitude of the enhancement varied considerably in different batches of eggs.
injected with a similar plasmid containing an SV40 pro- would block dorsal axis formation induced by DN-GSK-3,
as DN-GSK-3 is not expected to act through depletion ofmoter in place of the collagenase promoter. Embryos were
then cultured in LiCl at the concentrations indicated in Fig. myo-inositol. mRNA encoding DN-GSK-3 was injected into
a ventral±vegetal cell of 16-cell embryos with or without4 and harvested at stage 12, when endogenous c-jun activity
becomes detectable according to previously published data myo-inositol present. Embryos were then scored at later
stages for second axis formation. As shown in Table 1 and(Dong et al., 1996). Luciferase activity was determined in
embryo lysates. In untreated embryos, there is a low level Fig. 5, coinjection of myo-inositol clearly reduced the fre-
quency and the extent of second axis induction by DN-of luciferase activity (Fig. 4), but in the presence of LiCl
this activity is increased more than 20-fold, consistent with GSK-3. The most striking effect is on the anterior extent of
the ectopic axes that do form after coinjection of myo-inosi-lithium inhibition of GSK-3, thus preventing c-jun inhibi-
tion by GSK-3. A corresponding increase in AP-1 complex tol and DN-GSK-3. Even in those cases where anterior
structures such as cement gland are present (as indicatedformation is also seen (by gel retardation assay) in response
to lithium treatment (data not shown). In control embryos, in Table 1), they are markedly reduced in size compared to
those found with injection of DN-GSK-3 alone (not shown).the SV40 promoter±luciferase reporter yields a high level
of luciferase expression that is not affected by lithium treat- Myo-inositol did not inhibit the synthesis of DN-GSK-3
protein (data not shown) and also had no discernible effectment (Fig. 4B). The SV40 reporter is detectable much earlier
than the collagenase reporter, beginning at the midblastula on formation of the primary dorsal axis when injected into
transition rather than stage 11 to 12, and luciferase activity
reaches a level an order of magnitude higher than that from
the collagenase promoter in sibling embryos. The values TABLE 1
shown in Fig. 4B are thus normalized to maximum activity
from the respective promoters. Complete second axis Total second axis
DN-GSK-3 / DN-GSK-3 /
DN-GSK-3 myo-inositol DN-GSK-3 myo-inositol ControlMyo-inositol Blocks Ectopic Axis Induced
by DN-GSK-3 I 8/19 0/19 12/19 7/19 0/19
II 8/23 1/24 14/23 9/24 0/24Dorsalization of Xenopus embryos by lithium can be III 8/15 4/15 10/15 7/15 0/24
blocked by coinjection of myo-inositol (Busa and Gimlich,
Total 24/57* 5/58* 36/57* 23/58* 01989). This observation has lent strong support to the inosi-
% 42 9 63 40tol depletion hypothesis. However, myo-inositol could
block dorsal axis induction by lithium through a more indi- * DN-GSK-3 / H2O is signi®cantly different from DN-GSK-3 /
rect mechanism that is independent of IMPase inhibition. myo-inositol in both formation of complete second axis and total
second axis with a P  0.05, by Waller±Duncan statistical analysis.To examine this possibility, we asked whether myo-inositol
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FIG. 5. Myo-inositol blocks ectopic axis induced by DN-GSK-3. Single ventral±vegetal blastomeres of 16-cell Xenopus embryos were
injected with DN-GSK-3 / H2O or DN-GSK-3 / myo-inositol and were scored for formation of ectopic dorsal axis through stage 35. The
panel on the left (DN-GSK-3) shows induction of a complete second axis with cement gland, head, and eyes. The panel on the right (DN-
GSK-3 / myo-inositol) shows an incomplete secondary axis without clear head structures. See Table 1.
dorsal blastomeres (data not shown; also reported pre- stabilization in Drosophila and Xenopus (Peifer et al., 1994;
Yost et al., 1996; van Leeuwen et al., 1994; reviewed inviously: Busa and Gimlich, 1989).
Miller and Moon, 1996). Genetic epistasis experiments in
Drosophila have shown that GSK-3b (zeste-white-3/shaggy)
antagonizes this pathway and dominant negative forms ofDISCUSSION
GSK-3 mimic activation of the pathway in Xenopus (Dom-
inguez et al., 1995; He et al., 1995; Pierce and Kimelman,The remarkable parallels between activation of GSK-3
1995). In addition, recent biochemical analysis has sug-regulated pathways and the effects of lithium on diverse
gested that wnt signaling inhibits GSK-3 enzymatic activitypathways have suggested a novel mechanism for lithium
(Cook et al., 1996). We show here that lithium, like domi-action, as proposed previously (Klein and Melton, 1996).
nant negative GSK-3, activates the wnt pathway by antago-Thus, GSK-3 inhibits the wnt signaling pathway, glycogen
nizing GSK-3 function, as assessed by stabilization of b-synthesis, and, in Dictyostelium, stalk cell speci®cation,
catenin in oocytes and embryos. Stabilization of b-cateninand in each case lithium treatment stimulates these path-
is seen for injected protein, but changes in endogenous lev-ways, consistent with direct inhibition of GSK-3 by lithium.
els are not detectable in our assays, presumably becauseThe data presented here demonstrate in vivo inhibition of
the majority of the endogenous protein is sequestered inGSK-3 by lithium and consequent downstream activation
complexes with cadherin and not accessible to regulationof the wnt signaling pathway in Xenopus laevis oocytes
by the wnt pathway (Fagatto and Gumbiner, 1994; Yost etand embryos. Similar conclusions were reached in recently
al., 1996; Schneider et al., 1996). We have also found thatpublished work using PC12 and S2 tissue culture cells
LiCl treatment of Drosophila S2 cells leads to accumulation(Stambolic et al., 1996). Both vertebrate (Xenopus as well
of armadillo protein (C. M. Hedgepeth and P. S. Klein, un-as mammalian) and invertebrate (Dictyostelium and Dro-
published data; see also Stambolic et al., 1996).sophila) forms of GSK-3b are inhibited by lithium, showing
Activation of the wnt pathway by lithium explains anthat the sensitivity of GSK-3 to lithium is conserved across
intriguing parallel between ectopic wnt expression anda broad phylogenetic spectrum. These data support the hy-
lithium treatment in Xenopus embryos: It has been ob-pothesis that inhibition of GSK-3 is a general mechanism
served previously that expression of Xwnt-8 prior to thefor lithium action in these settings and are consistent with
midblastula transition (MBT) results in dorsalization, asour previous ®ndings that puri®ed GSK-3 is inhibited by
discussed above, while expression of Xwnt-8 after MBTlithium in vitro (Klein and Melton, 1996).
results in truncations of dorsal±anterior structures (Chris-Activation of the wnt signaling pathway results in accu-
mulation of b-catenin or armadillo protein due to protein tian et al., 1991, 1993). Remarkably, the responses to lith-
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ium are very similar: exposure to lithium prior to MBT weeks to manifest a clinical response. It has been suggested
that this delay re¯ects changes in gene expression ratherdorsalizes and exposure after MBT leads to similar dorsal±
anterior truncations (Cooke and Smith, 1988; Yamaguchi than an immediate effect on signal transduction mecha-
nisms (Manji et al., 1995). Thus, lithium's ability to stimu-and Shinagawa, 1989).
Our assays show that b-catenin protein is being rapidly late AP-1 regulated transcription, as well as the nuclear
localization of b-catenin, suggests two mechanisms to con-turned over in oocytes (as previously shown in embryos).
Since this turnover can be inhibited by DN-GSK-3b (as well vert short-term responses to lithium into long-term changes
in gene expression.as by lithium), endogenous GSK-3 must be present and ac-
tive in the oocyte, although at a level below the sensitivity The inositol depletion hypothesis has been a compelling
and widely accepted explanation for the developmental ef-of the tau phosphorylation assay or of antibody detection.
It remains to be seen whether oocyte GSK-3 activity and b- fects of lithium. However, while lithium does inhibit IM-
Pase in vivo (Maslanski et al., 1992; Klein and Melton,catenin turnover represent a constitutive process or serve
an unknown function in the oocyte. At present, the ability 1996), a far more potent inhibitor of IMPase, L-690, 330,
does not dorsalize embryos, strongly suggesting that inhibi-to recapitulate part of the wnt signaling pathway in oocytes
will provide a valuable tool for studying the biochemistry tion of IMPase is not suf®cient for the developmental effects
of lithium. Why then does coinjection of myo-inositol re-of wnt signaling in an in vivo setting.
As an alternative assay of GSK-3b in embryos, we exam- verse the effect of lithium (Busa and Gimlich, 1989)? One
explanation could be that depletion of inositol is necessary,ined the activity of the transcription factor c-jun, which
binds DNA as part of the AP-1 complex (Angel and Karin, but not suf®cient, for the teratogenic effect of lithium. Al-
ternatively, injection of 0.3 M inositol could have a more1991). DNA binding and transcriptional activation by c-jun
have been shown by others to be inhibited by GSK-3 (Boyle indirect effect on ectopic axis formation that is unrelated
to partially depleted inositol pools. To distinguish betweenet al., 1991; de Groot et al., 1992; Nikolakaki et al., 1993).
Thus, our prediction was that lithium should activate c-jun these two possibilities, we tested whether inositol would
block dorsalization by factors not expected to deplete inosi-by inhibiting GSK-3. In untreated embryos, we observed a
low level of activity through an AP-1-dependent promoter tol. Thus, we have shown that injection of myo-inositol can
block dorsalization by DN-GSK-3. While the mechanism ofwhen compared to other promoters (e.g., SV40±luciferase),
but also observed a marked increase in the presence of lith- myo-inositol rescue is uncertain, it seems unlikely that
DN-GSK-3 is also acting through depletion of inositol.ium chloride, without any effect on the control promoter.
This observation is consistent with constitutive inhibition Rather, the data suggest that injected inositol or a metabo-
lite acts through some pathway independent of IMPase toof endogenous jun by GSK-3 which is then reversed by lith-
ium. However, it has not been technically possible to map reverse the consequences of inhibition of GSK-3, whether
that inhibition is mediated by lithium or through DN-GSK-the phosphorylation sites in c-jun after lithium treatment,
as the endogenous protein levels are very low in stage 12 3. It should be pointed out, however, that our data do not
rule out a role for IP3 signaling in axis determination inembryos (data not shown). Thus, it remains possible that
lithium activates AP-1-dependent transcription through al- Xenopus, independent of the effects of lithium. Indeed, arti-
®cial activation of phospholipase C in dorsal blastomeresternative mechanisms, including activation of jun N-termi-
nal kinases or activation of the fos protein, which can also causes ventralization of Xenopus embryos, raising the possi-
bility that IP3 and/or diacylglycerol are involved in ventralparticipate in AP-1 complex formation. Others have re-
ported that stimulation of AP-1 activity by NGF or pilocar- axis determination normally (Ault et al., 1996).
A number of other hypotheses have been advanced topine is enhanced by cotreatment with lithium, as deter-
mined by gel retardation assays (Bullock et al., 1994; Wil- explain the mechanism of lithium action, including but not
limited to inhibition of trimeric G-protein function and per-liams and Jope, 1995). We have also observed increased AP-
1 complex formation after lithium treatment, as measured turbation of ion ¯ux across membranes (reviewed in Gilman
et al., 1990; Jope and Williams, 1994). These hypothesesby gel retardation assays, consistent with inhibition of GSK-
3 by lithium (data not shown). However, these data do not have not been addressed directly in this work. In addition,
a family of structurally related enzymes, including fructosedistinguish whether the increase in AP-1 binding is due to
direct stimulation of c-jun or removal of an inhibitor of jun 1,6-bisphosphatase and inositol polyphosphate 1-phospha-
tase, has been identi®ed and shown to be inhibited by lith-activity.
Thus, three lines of evidence argue that lithium inhibits ium (York et al., 1995). The possibility that these enzymes
play a role in signal transduction and the pharmacology ofGSK-3 activity in embryos: (1) Lithium leads to stabilization
ofb-catenin protein in Xenopus embryos, as well as oocytes; lithium action is currently under study (J. York, personal
communication).(2) lithium stimulates nuclear translocation of b-catenin in
Xenopus embryos (Schneider et al., 1996) as well as sea Inhibition of GSK-3b by lithium offers a highly plausible
molecular mechanism for the effects of lithium on develop-urchin embryos (J. R. Miller and D. R. McClay, personal
communication); and (3) lithium appears to activate AP-1 ment in diverse organisms from Dictyostelium to verte-
brate embryos and this hypothesis is strongly supported byactivity in Xenopus embryos as well as mammalian cells.
In the treatment of manic-depressive disorder, lithium does genetic as well as biochemical data. The intriguing possibil-
ities that GSK-3b is the target of lithium in the treatmentnot have an immediate effect, but rather requires several
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Cook, D., Fry, M. J., Hughes, K., Sumathipala, R., Woodgett, J. R.,of bipolar disorder and that this hypothesis may also explain
and Dale, T. C. (1996). Wingless inactivates glycogen synthasethe stimulatory effect of lithium on hematopoiesis are cur-
kinase-3 via an intracellular signalling pathway which involvesrently under investigation.
a protein kinase C. EMBO J. 15, 4526±4536.
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